Treatment of hepatitis C after liver transplantation.
This article summarizes the current therapies, with particular emphasis on antiviral therapy. Because these alternatives have substantial limitations, pretransplant or early post-transplant recognition of patients with high risk of severe post-transplantation outcome is desirable to target these patients for intervention. Alternatively, the implementation of measures aimed at reducing or avoiding factors known to be associated with an aggressive recurrence is an additional strategy that needs to be explored.
Berenguer
Marina
M
Hospital Universitario La FE, Servicio de Medicina Digestiva, Avenida Campanar 21, Valencia, 46009 Spain. mbhaym@teleline.es
D000998:Antiviral Agents / Q000627:therapeutic use; D006526:Hepatitis C / Q000150:complications / Q000628:therapy*; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D017093:Liver Failure / Q000209:etiology / Q000601:surgery; D016031:Liver Transplantation; D011379:Prognosis; D012008:Recurrence
D000998:Antiviral Agents; D016756:Immunoglobulins, Intravenous